Iron Overload in Haemochromatosis
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Walker R, Miller J, Dymock I, Shilkin K, Williams R Gut. 1971; 12(12):1011-4.
PMID: 5157130 PMC: 1411991. DOI: 10.1136/gut.12.12.1011.
References
1.
Smith P, Studley F, Williams R
. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test. Lancet. 1967; 1(7482):133-6.
DOI: 10.1016/s0140-6736(67)91035-5.
View
2.
DAVIS P, Luke C, Deller D
. Reduction of gastric iron-binding protein in haemochromatosis. A previously unrecognised metabolic defect. Lancet. 1966; 2(7479):1431-3.
DOI: 10.1016/s0140-6736(66)90594-0.
View
3.
Wapnick A, Lynch S, Krawitz P, SEFTEL H, CHARLTON R, BOTHWELL T
. Effects of iron overload on ascorbic acid metabolism. Br Med J. 1968; 3(5620):704-7.
PMC: 1989646.
DOI: 10.1136/bmj.3.5620.704.
View
4.
WELLS D, Baylis E, Holoway L, Marks V
. Erythrocyte-transketolase activity in megaloblastic anaemia. Lancet. 1968; 2(7567):543-5.
DOI: 10.1016/s0140-6736(68)92412-4.
View
5.
Smith P, LESTAS A, Miller J, Dymock I, Pitcher C, Williams R
. The differential ferrioxamine test in the management of idiopathic haemochromatosis. Lancet. 1969; 2(7617):402-5.
DOI: 10.1016/s0140-6736(69)90112-3.
View